The six-year prevalence of Crimean-Congo Hemorrhagic Fever (CCHF) in Erzurum, Turkey.

IF 0.8 4区医学 Q4 INFECTIOUS DISEASES

Journal of Vector Borne Diseases Pub Date : 2024-07-07 DOI:10.4103/JVBD.JVBD_143_21

Hakan Igan, Hayrunisa Hanci

{"title":"The six-year prevalence of Crimean-Congo Hemorrhagic Fever (CCHF) in Erzurum, Turkey.","authors":"Hakan Igan, Hayrunisa Hanci","doi":"10.4103/JVBD.JVBD_143_21","DOIUrl":null,"url":null,"abstract":"Background objectives: Crimean-Congo Hemorrhagic Fever disease (CCHF) is a potentially deadly viral disease and Turkey is the country in which the disease is seen the most. The purpose of this study is to estimate the frequency and case fatality ratio (CFR) of CCHF disease in Erzurum/Turkey between years 2015-2021.Methods: The CCHF positivity in patients was detected on serum samples via RT-PCR method with RNA detection. Demographic data belonging to positive patients, such as, age, sex, region of residence, tick contact was analyzed retrospectively.Results: It was detected that the RT-PCR test of 521 patients out of a total of 1378 sent to the laboratory were positive. Each sample belonged to a single patient and repeating samples were left out of the research. The year with least positive patient ratio in relation to potential CCHF positive samples was 2017 (21.12%) whereas the year with the most positivity ratio was 2020 (55.48%) The case fatality ratio in the six-year period was calculated to be 1.34%.Interpretation conclusion: This study has demonstrated that there is a significant rise in CCHF patient numbers, especially in 2020 when the Covid-19 pandemic started. In order to prevent this rise, it is crucial that the effect of Covid-19 pandemic on the increase in interactions of humans with ticks is researched thoroughly, a biological intervention is made and the public awareness on CCHF disease is increased.","PeriodicalId":17660,"journal":{"name":"Journal of Vector Borne Diseases","volume":null,"pages":null},"PeriodicalIF":0.8000,"publicationDate":"2024-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Vector Borne Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4103/JVBD.JVBD_143_21","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}

引用次数: 0

Abstract

Background objectives: Crimean-Congo Hemorrhagic Fever disease (CCHF) is a potentially deadly viral disease and Turkey is the country in which the disease is seen the most. The purpose of this study is to estimate the frequency and case fatality ratio (CFR) of CCHF disease in Erzurum/Turkey between years 2015-2021.

Methods: The CCHF positivity in patients was detected on serum samples via RT-PCR method with RNA detection. Demographic data belonging to positive patients, such as, age, sex, region of residence, tick contact was analyzed retrospectively.

Results: It was detected that the RT-PCR test of 521 patients out of a total of 1378 sent to the laboratory were positive. Each sample belonged to a single patient and repeating samples were left out of the research. The year with least positive patient ratio in relation to potential CCHF positive samples was 2017 (21.12%) whereas the year with the most positivity ratio was 2020 (55.48%) The case fatality ratio in the six-year period was calculated to be 1.34%.

Interpretation conclusion: This study has demonstrated that there is a significant rise in CCHF patient numbers, especially in 2020 when the Covid-19 pandemic started. In order to prevent this rise, it is crucial that the effect of Covid-19 pandemic on the increase in interactions of humans with ticks is researched thoroughly, a biological intervention is made and the public awareness on CCHF disease is increased.

查看原文本刊更多论文

土耳其埃尔祖鲁姆的克里米亚-刚果出血热（CCHF）六年流行率。

背景目标：克里米亚-刚果出血热疾病（CCHF）是一种可能致命的病毒性疾病，土耳其是该疾病发病率最高的国家。本研究旨在估算2015-2021年间埃尔祖鲁姆/土耳其克里米亚-刚果出血热疾病的发病频率和病死率（CFR）：方法：通过 RT-PCR 方法检测血清样本中的 RNA，检测患者的 CCHF 阳性率。回顾性分析了阳性患者的人口统计学数据，如年龄、性别、居住地区、蜱虫接触情况等：在送往实验室的 1378 份样本中，有 521 份样本的 RT-PCR 检测结果呈阳性。每个样本只属于一名患者，重复样本不在研究范围内。在潜在的 CCHF 阳性样本中，阳性患者比例最低的年份是 2017 年（21.12%），而阳性比例最高的年份是 2020 年（55.48%），经计算，六年期间的病死率为 1.34%.解读结论：本研究表明，慢性阻塞性肺疾病患者人数显著增加，尤其是在 Covid-19 大流行开始的 2020 年。为了防止这种上升，必须深入研究 Covid-19 大流行对人类与蜱虫相互作用增加的影响，采取生物干预措施，并提高公众对 CCHF 疾病的认识。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Vector Borne Diseases INFECTIOUS DISEASES-PARASITOLOGY

CiteScore

0.90

自引率

0.00%

发文量

审稿时长

>12 weeks

期刊介绍： National Institute of Malaria Research on behalf of Indian Council of Medical Research (ICMR) publishes the Journal of Vector Borne Diseases. This Journal was earlier published as the Indian Journal of Malariology, a peer reviewed and open access biomedical journal in the field of vector borne diseases. The Journal publishes review articles, original research articles, short research communications, case reports of prime importance, letters to the editor in the field of vector borne diseases and their control.